Effectiveness and Safety of Epivir/Ziagen/Zerit (3TC/ABC/d4T) Versus Epivir/Ziagen/Sustiva (3TC/ABC/EFV) Versus Epivir/Ziagen/Agenerase/Norvir (3TC/ABC/APV/RTV) in HIV Patients Who Have Never Received Treatment

Name: Effectiveness and Safety of Epivir/Ziagen/Zerit (3TC/ABC/d4T) Versus Epivir/Ziagen/Sustiva (3TC/ABC/EFV) Versus Epivir/Ziagen/Agenerase/Norvir (3TC/ABC/APV/RTV) in HIV Patients Who Have Never Received Treatment
License: Public Domain

Glaxo Wellcome

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

anti-hiv-agents combination drug-therapy hiv-1 hiv-infections

hiv infections, hiv-1, drug therapy, combination, stavudine, hiv protease inhibitors, ritonavir, lamivudine, vx 478, reverse transcriptase inhibitors, anti-hiv agents, abacavir, efavirenz

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 876734
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.